| Trial ID: | L5796 |
| Source ID: | NCT03039075
|
| Associated Drug: |
Metformin Sr Tablet
|
| Title: |
Metformin SR Tablet (DuLeNing) and Glucophage in Patients With Type 2 Diabetes
|
| Acronym: |
CQM-2016
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus
|
| Interventions: |
DRUG: Metformin SR Tablet
|
| Outcome Measures: |
Primary: Changes of HbA1c, Efficacy, 12 weeks | Secondary: Incidence of nausea, diarrhea, Safety, 12 weeks|Changes of weight, 12 weeks|Changes of intestinal flora proportion, 12 weeks|Changes of LDL, HDL, TG, TC, blood lipid, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Chongqing Medical University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
240
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2016-11
|
| Completion Date: |
2018-11
|
| Results First Posted: |
|
| Last Update Posted: |
2019-07-24
|
| Locations: |
The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, 400016, China
|
| URL: |
https://clinicaltrials.gov/show/NCT03039075
|
